Packages containing COVID-19 pharmaceuticals accompanied by data loggers and/or cargo tracking devices containing lithium batteries are not subject to the marking and documentation requirements of Section II of Packing Instruction 967 or 970, as applicable.

This same package configuration, when consigned without the COVID-19 pharmaceutical for the purpose of use or reuse, is also not subject to the marking and documentation requirements of Section II of Packing Instruction 967 or 970, as applicable, provided prior arrangements have been made with the operator.